Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-24 @ 7:51 PM
NCT ID:
NCT04242004
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients
* Age ≥18 years
* Established diagnosis of HIV-1 infection, under stable cART for the prior 6 months and throughout the study period
* Presence of neurocognitive impairment was assessed using the global deficit score (GDS), calculated as the average of deficit scores across all neuropsychological test. The cut-off for NCI was a GDS score ≥ 0.5
Exclusion Criteria:
* Age \<18 years,
* BMI \>30 kg/m2
* Pregnancy or lactation
* A history of diabetes mellitus, cardiovascular and cerebrovascular diseases, or serious diseases such as liver, kidney and hematopoietic system disease
* Known intolerance to n-3 PUFA preparations.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04242004
Study Brief:
Protocol Section:
NCT04242004